Blue Jet Healthcare IPO GMP Price Today, Details, Date

Advertisement

Advertisement

Dear Investor, a new IPO is about to come into the markets named Blue Jet Healthcare IPO. Blue Jet Healthcare IPO is opening on 25 October 2023 and this IPO is going to close on 27 October 2023. IRM Energy IPO allotment is on 01st November, refund is on 01St November, share credit in demat account will be on 3rd November, and Blue Jet Healthcare IPO listing will be on 06 November. Blue Jet Healthcare IPO will be listed on BSE and NSE. Promoter holding of Blue Jet Healthcare IPO is 67%. Chanting is very good. Blue Jet Healthcare IPO Link is registered with Intime India Private Ltd.

Dear investors Check out Bluejet Healthcare Ltd IPO GMP Today. We regularly update Grey Market Premium Today About all IPO. Blue Jet Healthcare IPO GMP today is ₹15. Blue Jet Healthcare IPO’s estimated listing price is ₹361 (cap price + today’s GMP).

Blue Jet Healthcare IPO Date 

  • Open – October 25, 2023
  • Close – October 27, 2023
  • Basis of Allotment – November 01, 2023
  • Refunds – November 01, 2023
  • A credit of Shares to Demat AC – November 3, 2023
  • Listing Date – November 06, 2023

Blue Jet Healthcare IPO Price, Lot Size

  • Face Value: ₹2 per share
  • Price Range: ₹329 to ₹346 per share
  • Lot Size: 43
  • Total Issue Size: 24,285,160 shares (aggregating up to ₹840.27 Cr)
  • Fresh Issue: 24,285,160 shares of ₹2 (aggregating up to ₹840.27 Cr)
  • Issue Type: Book Built Issue IPO
  • Listing At: BSE, NSE

Blue Jet Healthcare IPO GMP Today Price | Gray Markets Price Today

Per the last update on October 27, 2023, at 11 AM, the latest GMP (Gray Markets Price) for Blue Jet Healthcare Limited IPO is ₹15. The base price of the IPO is ₹346, with an estimated listing price of ₹361 (4.34%)    (cap price + today’s GMP). This suggests an expected profit per share of 4.34%.

Also Read this

IRM Energy IPO GMP Today

Date GMP Subject to Sauda IPO Price
Estimated Listing Price
27 October ₹15 7000 346 ₹361 (4.34%)
26 October ₹10 4200 346 ₹356 (2.89%)
25 October ₹34 15400 346 ₹380 (9.83%)
24 October ₹63 39200 346 ₹409 (18.21%)
23 October ₹63 39200 346 ₹409 (18.21%)
22 October ₹63 39200 346 ₹409 (18.21%)
21 October ₹85 39200 346 ₹431 (24.46%)
20 October ₹85 39200 346 ₹431 (24.46%)
19 October ₹95 43400 346 ₹441 (27.46%)

 

Advertisement

Advertisement

Blue Jet Healthcare Limited IPO GMP estimates that the Share Price is ₹361 (GMP + IPO price)

About Blue Jet Healthcare Limited

Overview

Blue Jet Healthcare Limited, founded in 1968, is a prominent pharmaceutical and healthcare ingredient company with a rich history. It was the pioneering manufacturer of saccharin and its salts (artificial sweeteners) in India. Over the years, Blue Jet Healthcare expanded into producing contrast media intermediates for use in CT scans and MRIs. The company specializes in three key product categories:

  1. Contrast Media Intermediates
  2. High-Intensity Sweeteners
  3. Pharma Intermediates and Active Pharmaceutical Ingredients (API)

Company Profile

Blue Jet Healthcare is a globally recognized, science-driven pharmaceutical firm known for its extensive capabilities, global regulatory support, and collaborative approach. The company is involved in:

  • Process Development and Production: Blue Jet Healthcare offers advanced process development and production capabilities.
  • Global Regulatory Support: The company provides comprehensive regulatory support on a global scale.
  • Collaboration and Manufacturing: Blue Jet Healthcare collaborates on the development and manufacturing of advanced pharmaceutical intermediates and APIs.

The company operates three state-of-the-art manufacturing facilities, strategically located in Maharashtra, India. These facilities have significant annual installed capacities as of June 30, 2023:

  • Unit I (Shahad): 200.60 KL
  • Unit II (Ambernath): 607.30 KL
  • Unit III (Mahad): 213.00 KL

Core Strengths

Blue Jet Healthcare’s success is built on several core strengths, including:

  1. Huge Manufacturing Capacity: The company boasts a substantial manufacturing capacity for contrast media intermediates in India.
  2. Niche Market Expertise: Blue Jet Healthcare operates in a niche market with high entry barriers, which strengthens its competitive position.
  3. Long-Term Relationships: The company has fostered long-term relationships and secured contracts with multinational customers, enhancing its stability and growth potential.

Financial Performance

Here’s a snapshot of Blue Jet Healthcare Limited’s financial performance, with data restated for clarity:

Financial Year-End Comparison

Period Ended 30 Jun 2023 31 Mar 2023 31 Mar 2022 31 Mar 2021
Assets ₹903.80 Cr ₹862.07 Cr ₹713.38 Cr ₹536.27 Cr
Revenue ₹184.60 Cr ₹744.94 Cr ₹702.88 Cr ₹507.81 Cr
Profit After Tax ₹44.12 Cr ₹160.03 Cr ₹181.59 Cr ₹135.79 Cr
Net Worth ₹725.68 Cr ₹681.49 Cr ₹521.54 Cr ₹339.82 Cr
Reserves and Surplus
Total Borrowing

Notably, Blue Jet Healthcare Limited experienced a 5.98% increase in revenue, while its profit after tax (PAT) decreased by -11.88% between the financial years ending on March 31, 2023, and March 31, 2022.

Blue Jet Healthcare Limited IPO GMP FAQs

  1. What is Blue Jet Healthcare Limited IPO GMP Today?

    The Blue Jet Healthcare Limited IPO GMP aka Grey Market Premium is ₹15.

  2. What are Blue Jet Healthcare Limited’s IPO Kostak Rates Today?

    The Blue Jet Healthcare Limited IPO Kostak Rate is ₹ 2500.

  3. What is Blue Jet Healthcare Limited IPO Subject to Sauda Price Today?

    The Blue Jet Healthcare Limited IPO subject to sauda price is 7000.

  4. Blue Jet Healthcare Limited IPO Expected Returns?

    The Blue Jet Healthcare Limited IPO’s expected return is ₹361 per share (4.34%)

  5. Who is the owner of Blue Jet Healthcare Limited?

    Shiven Akshay Arora, Akshay Bansarilal Arora, and Archana & Akshay Arora owner of Blue Jet Healthcare Limited.

Leave a Comment

Tata Technologies share price target 2023 आज खुलने जा रहा है सरकारी कंपनी का IPO, दाम 50 रुपये से भी कम,